That instinct can save lives when cardiac events occur
Research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, originally developed to manage Type 2 diabetes, may be able to treat a wide range of conditions involving impulse control, like binge eating disorder.But although there may be tantalizing clues for helping patients with unwanted impulses, GLP-1 and GIP inhibitors may not be optimally designed to treat them sufficiently and need further research, according to a case study from the Perelman School of Medicine at the University of Pennsylvania, published today in Nature Medicine
Food noise and cravings management: Mindfulness and urge surfing : Practice observing cravings without immediately acting
[DOI] [PubMed] [Google Scholar] 28.Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK: Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men
Poznyak AV, Nikiforov NG, Markin AM, Kashirskikh DA, Myasoedova VA, Gerasimova EV, et al
Taking a combination of B12 is also found to improve B12 status more effectively than taking a single form
